Skip to content
Disclosery

13F-HR filed by Catalio Capital Management, LP

Catalio Capital Management, LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 39 holding rows worth $532,102,416.

Accession
0001958125-26-000005
Filer
CIK 1958125
Filed
2026-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2026

A holdings report, 39 entries on the cover page, a total value of $532,102,416 stated on the cover page (in dollars after the unit check, H1), rows summing to $532,102,416 with VALUE read as dollars as filed, 13F file number 028-25237. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AVALYN PHARMA INC05348Y105COMMON STOCK1,675,830$55,168,324dollars as filed
Johnson & Johnson478160104COM138,946$35,288,116dollars as filed
Gilead Sciences,Inc.375558103COM269,309$34,024,499dollars as filed
BRIDGEBIO PHARMA INC10806X102COM455,041$33,891,454dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM1,215,698$26,575,158dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS562,672$26,468,091dollars as filed
Bristol-Myers Squibb Company110122108COM412,961$23,794,813dollars as filed
PARABILIS MEDICINES INC COM698955101Stock824,043$22,554,057dollars as filed
NATERA INC COM632307104Stock82,181$22,308,032dollars as filed
INCYTE CORP COM45337C102Stock191,627$21,722,837dollars as filed
SEPTERNA INC COM81734D104Stock536,152$17,955,730dollars as filed
MINERALYS THERAPEUTICS INC603170101COM648,722$17,502,520dollars as filed
HEARTFLOW INC42238D107COM583,055$17,106,834dollars as filed
CORVUS PHARMACEUTICALS INC221015100COM1,080,888$16,148,467dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY276,550$14,842,438dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM106,799$13,091,421dollars as filed
DISC MEDICINE INC COM254604101Stock159,384$11,657,346dollars as filed
EDWARDS LIFESCIENCES CORP COM28176E108Stock124,778$11,287,418dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock43,182$10,569,658dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM316,252$10,559,654dollars as filed
KAILERA THERAPEUTICS INC482931102COMMON STOCK468,750$10,326,563dollars as filed
KARYOPHARM THERAPEUTICS INC48576U205COMMON STOCK940,855$9,192,153dollars as filed
Odyssey Therapeutics, Inc.67613T104COMMON STOCK457,839$8,566,168dollars as filed
ASCENDIS PHARMA A/SK08588103ORD SHS *A*31,759$8,470,760dollars as filed
KARDIGAN INC485925101CMN312,500$7,453,125dollars as filed
ELEDON PHARMACEUTICALS INC28617k101COM1,695,071$6,678,580dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock471,254$6,267,678dollars as filed
VERADERMICS INC922967104COMMON STOCK45,856$5,637,537dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock244,929$5,439,873dollars as filed
FRACTYL HEALTH INC35168W103COM6,168,749$4,900,454dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR148,045$4,700,429dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM32,941$3,211,089dollars as filed
BRIDGEBIO ONCOLOGY THERAPEUT107924102COM NEW318,407$2,426,261dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK520,148$1,986,965dollars as filed
HYPERFINE INC44916K106Common Stock1,320,041$1,782,055dollars as filed
ATAIBECKLEY INC04650F101COM SHS196,858$1,037,442dollars as filed
METAGENOMI THERAPEUTICS INC59102M104COM528,993$629,502dollars as filed
OUTSET MED INC690145206COM NEW118,279$510,965dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW14,718$367,950dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001958125-26-000005this filing2026-08-14acceptance time not in the bulk data set